Bass, Berry & Sims member Kevin Douglas is quoted in the Reuters article, “Icahn raises Clorox offer to $80 a share,” discussing activist investor Carl Icahn’s latest offer to buy Clorox Co. Drawing upon his experience handling cases involving activist investors, takeovers, and proxy fights, Mr. Douglas explains why Icahn’s move to raise his bid to $80 a share will likely not be seen as adequate or credible.